Papers
1
Total Citations
2
H-Index
1
About
Liu Huang has made significant contributions to the field of gynecologic oncology, with a particular focus on the standardization and refinement of clinical guidelines for cervical cancer management. As a key figure in the development of the NCCN (National Comprehensive Cancer Network) guidelines, Huang's work has directly shaped evidence-based practices for the diagnosis and treatment of cervical cancer. Their most cited paper, "Updates in version 1.2019 of the NCCN guidelines for cervical cancer from version 1.2018," with 2 citations, details critical revisions that enhanced clinical decision-making. Notably, this update elevated the recommendation for examination under anesthesia (EUA) with cystoscopy from "optional" to a consideration, and introduced fertility-sparing options for early-stage patients. These changes reflect Huang's dedication to improving patient outcomes through precise, actionable guidelines. By systematically updating and clarifying treatment pathways for stages IA1 with LVSI and IA2, Huang has helped clinicians navigate complex fertility-preserving strategies. Their work underscores a commitment to translating research into practical, life-changing clinical protocols, impacting both oncologists and patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1